IIL invests Rs 700 cr in new vaccine plant to combat FMD and HS
Biotechnology company Indian Immunologicals (IIL), under the National Dairy Development Board (NDDB), on Thursday announced the start of the construction of its new vaccine manufacturing plant at Genome Valley, Hyderabad. The company is investing around Rs 700 crore in this facility. Equipped with a BSL3 (biosafety level) facility for drug substance production and a Fill-Finish […]